Dr. Reddy's Laboratories Ltd. (RDY)
13.75
0.00 (0.00%)
USD |
NYSE |
Oct 27, 16:00
13.75
0.00 (0.00%)
After-Hours: 20:00
Dr. Reddy's Laboratories Gross Profit Margin (Quarterly) : 48.82% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 48.82% |
| June 30, 2026 | 42.70% |
| March 31, 2026 | 40.43% |
| December 31, 2025 | 50.27% |
| September 30, 2025 | 54.67% |
| June 30, 2025 | 53.62% |
| March 31, 2025 | 55.56% |
| December 31, 2024 | 57.68% |
| September 30, 2024 | 56.86% |
| June 30, 2024 | 57.64% |
| March 31, 2024 | 58.57% |
| December 31, 2023 | 55.60% |
| September 30, 2023 | 56.35% |
| June 30, 2023 | 55.79% |
| March 31, 2023 | 57.17% |
| December 31, 2022 | 56.74% |
| September 30, 2022 | 59.07% |
| June 30, 2022 | 46.76% |
| March 31, 2022 | 52.87% |
| December 31, 2021 | 50.85% |
| September 30, 2021 | 53.42% |
| June 30, 2021 | 49.08% |
| March 31, 2021 | 53.67% |
| December 31, 2020 | 50.37% |
| September 30, 2020 | 50.42% |
| Date | Value |
|---|---|
| June 30, 2020 | 52.40% |
| March 31, 2020 | 51.46% |
| December 31, 2019 | 50.75% |
| September 30, 2019 | 54.20% |
| June 30, 2019 | 47.99% |
| March 31, 2019 | 52.42% |
| December 31, 2018 | 50.16% |
| September 30, 2018 | 51.48% |
| June 30, 2018 | 52.22% |
| March 31, 2018 | 53.45% |
| December 31, 2017 | 52.87% |
| September 30, 2017 | 49.73% |
| June 30, 2017 | 51.56% |
| March 31, 2017 | 47.68% |
| December 31, 2016 | 55.50% |
| September 30, 2016 | 52.34% |
| June 30, 2016 | 52.28% |
| March 31, 2016 | 56.64% |
| December 31, 2015 | 57.20% |
| September 30, 2015 | 59.19% |
| June 30, 2015 | 59.15% |
| March 31, 2015 | 53.02% |
| December 31, 2014 | 56.66% |
| September 30, 2014 | 56.97% |
| June 30, 2014 | 57.68% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 57.57% |
| Teva Pharmaceutical Industries Ltd. | 52.07% |
| AstraZeneca PLC | 76.09% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.32% |
| Return on Assets | 4.90% |
| Return on Invested Capital | 6.19% |
| Profit Margin (Quarterly) | 10.53% |
| Operating Margin (Quarterly) | 13.81% |
| Return on Net Operating Assets | 6.70% |